Catenion
- Company typePrivate
- Founded2003
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
Catenion firmographics
Firmographics- Name
- Catenion
- Legal name
- Catenion GmbH
- Website
- https://catenion.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Where Catenion is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices5 records
Markets served
Catenion business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Management Consulting Services: Catenion generates revenue through bespoke consulting engagements with pharmaceutical, biotech, and medical device companies. Engagements cover corporate and R&D strategy, asset/company screening, portfolio review, target prioritization, therapeutic area strategy, clinical development strategy, science and technology mapping, R&D risk assessment, and due diligence. Revenue is project-based and typically involves multi-month engagements with senior executives.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Catenion product offering
Product offeringCore offering
Catenion is a science-driven management consulting firm that delivers bespoke strategic advisory services to pharmaceutical, biotechnology, medical device, government, and academic clients. Its offerings span corporate and R&D strategy, asset and company screening, portfolio review and optimization, target selection and prioritization, therapeutic area strategy and disease mapping, clinical development strategy, R&D risk assessment, science and technology mapping, due diligence, and market research, all supported by an in-house Data Science Unit and proprietary analytical tools.
Product overview
Catenion is a management consulting firm focused on science-driven strategy for the pharmaceutical and biotech industry. The company offers a comprehensive suite of consulting services organized around R&D strategy and corporate advisory, including Corporate and R&D Strategy, Asset & Company Screening (via the proprietary ASAP methodology), Portfolio Review & Optimization, Target Selection & Prioritization, Therapeutic Area Strategy & Disease Mapping, Clinical Development Strategy, R&D Risk Assessment (using a proprietary tool with 500+ criteria), Due Diligence, Science & Technology Mapping, Market Research, and Catenion Academy training programs. These services are powered by a dedicated Data Science Unit comprising bioinformaticians, computational biologists, and data engineers who develop and apply machine learning and state-of-the-art computational techniques, integrating genomic, proteomic, clinical, competitive, and market data into proprietary knowledge graphs to support all consulting engagements.
Differentiator
Problem solved
Functional benefit
Products and services
- Corporate and R&D Strategy
- ASAP (Accelerated Search & Acquisition Process)
- Portfolio Review & Optimization
- Target Selection & Prioritization
- Therapeutic Area Strategy & Disease Mapping
- Indication Evaluation & Therapeutic Expansion
- Clinical Development Strategy
- R&D Risk Assessment
- Due Diligence
- Science & Technology Mapping
- Market Research
- Catenion Academy
Quantifiable outcome
- 1,500+ R&D projects assessed using proprietary tools across the biopharmaceutical industry
- +2 more outcomes
Companies that use Catenion
Customer profileNamed customers20 records
Segments4 records
Ideal customer profiles4 records
Catenion technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Catenion partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Catenion competitors and assessment
Company assessmentDirect peers
- Charles River Associates (CRA): CRA's Life Sciences practice provides strategy and due diligence consulting to pharma and biotech on R&D portfolio optimization, asset valuation, and commercial strategy. Direct overlap with Catenion's portfolio review, ASAP-style asset screening, and due diligence offerings for investors and corporate clients.
- Putnam Associates: Putnam is a boutique life sciences strategy consultancy focused on biopharma commercial and pipeline strategy. Like Catenion, it serves a Big Pharma client base with science-driven engagements, though it leans more heavily into commercial and market access rather than early-stage R&D.
- LEK Consulting: LEK is a global strategy consulting firm with a dedicated Life Sciences practice advising pharma, biotech, and medtech clients on R&D, commercial strategy, and M&A. Like Catenion, it serves senior biopharma executives with bespoke strategic engagements, but operates at materially larger scale and broader service breadth.
- ZS Associates: ZS is a large consulting firm focused on pharma and biotech commercial and R&D strategy, with deep data and analytics capabilities. Comparable to Catenion in serving senior biopharma decision-makers, but at substantially greater scale and with broader technology/data product offerings.
- Lumanity: Lumanity is a biopharma-focused consulting and commercialization firm offering strategic advisory, evidence, and access services to pharma and biotech. Comparable peer for life sciences strategy engagements, particularly in portfolio/asset strategy and commercial due diligence.
- Trinity Partners: Trinity is a life sciences-focused consulting firm advising biopharma on commercial strategy, market access, and portfolio decisions. Direct peer in serving mid-to-large biopharma with strategic engagements, though with greater emphasis on commercial and pricing analytics than Catenion's R&D-focused methodology.
Broad incumbents
- Boston Consulting Group (Healthcare): BCG's Healthcare practice advises Big Pharma and biotech on R&D transformation, launch, and portfolio strategy. Comparable at the strategic mandate level but at global incumbent scale; BCG often competes with Catenion on top-priority pharma strategy engagements.
- Bain & Company (Healthcare): Bain's Healthcare practice delivers R&D, commercial, and M&A advisory to biopharma clients. Overlaps with Catenion in serving senior pharma executives on portfolio and asset strategy, but with broader industry coverage and significantly larger engagement teams.
- McKinsey & Company (Pharma & Medical Products): McKinsey's Pharma & Medical Products practice advises the largest global biopharma companies on R&D productivity, portfolio strategy, and M&A. Catenion competes for the same board-level strategic mandates, but McKinsey brings multi-thousand-consultant scale and broader functional coverage, while Catenion competes on science depth and PhD-led analysis.
Emerging players
- Defined Health / Cello Health (now part of PharmaLex): Defined Health was a boutique biopharma strategy consultancy providing therapeutic area strategy and asset diligence to biotech and pharma. Closely aligned with Catenion's boutique model and target customer profile, though smaller and more US-centric in its historical footprint.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Catenion social profiles
Digital presenceCatenion financial estimates
Financial estimateRevenue estimate
Valuation estimate
Catenion leadership team
Management profileNumber of profiles
Profiles9 records
Catenion funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Catenion M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Catenion
What does Catenion do?
Catenion is a science-driven management consulting firm that delivers bespoke strategic advisory services to pharmaceutical, biotechnology, medical device, government, and academic clients. Its offerings span corporate and R&D strategy, asset and company screening, portfolio review and optimization, target selection and prioritization, therapeutic area strategy and disease mapping, clinical development strategy, R&D risk assessment, science and technology mapping, due diligence, and market research, all supported by an in-house Data Science Unit and proprietary analytical tools.
Is Catenion a public or private company?
Catenion is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Catenion founded?
Catenion was founded in 2003. It employs 11 to 50 people.
Where is Catenion based?
Catenion is headquartered in Berlin, Germany, in the Europe region.
How does Catenion make money?
One revenue line is on record: management Consulting Services.
Who are Catenion's main competitors?
Direct peers on record are Charles River Associates (CRA), Putnam Associates, LEK Consulting, ZS Associates, Lumanity and Trinity Partners. Broad incumbents are Boston Consulting Group (Healthcare), Bain & Company (Healthcare) and McKinsey & Company (Pharma & Medical Products). Defined Health / Cello Health (now part of PharmaLex) is listed as an emerging player.
Does Catenion have an API?
No public API is recorded for Catenion.